SG
NKGNW

StoneX Group’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

StoneX Group’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,800
Closed -$2.07K – 486
2023
Q1 		$2.07K Sell
14,800
-26,229
-64% -$3.73K ﹤0.01% 399
2022
Q4 		$3.48K Buy
+41,029
New +$3.45K ﹤0.01% 511

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

StoneX Group's NKGNW Position: Q2 2023 in Review

StoneX Group sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q2 2023, closing a stake of 14,800 shares — an estimated $2.07K sold.

StoneX Group first reported a position in NKGNW in Q4 2022 and held it in 2 quarters. The position peaked at $3.48K in Q4 2022. 35 funds tracked by Wall St. Rank hold NKGNW as of Q2 2023.

  • StoneX Group reported no remaining NKGen Biotech, Inc. Warrants position as of Q2 2023 after selling out during the quarter.
  • StoneX Group sold 14,800 NKGen Biotech, Inc. Warrants shares in Q2 2023, an estimated $2.07K.
  • StoneX Group first reported a position in NKGen Biotech, Inc. Warrants in Q4 2022 and held it in 2 quarters.
  • StoneX Group's NKGen Biotech, Inc. Warrants position peaked at $3.48K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q2 2023.

Based on StoneX Group's 13F filing for Q2 2023, filed 14 Aug 2023.